HLUBF
H. Lundbeck AS - Ordinary Shares - Class A

2
Loading...
Loading...
H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders. Its product portfolio targets the following diseases: Alzheimer's, depression, Parkinson's, Schizophrenia, alcohol dependence, anxiety, bipolar disorder, epilepsy, and Huntington's. It operates through the following geographical segments: Europe, United States, and International Markets. The company was founded by Hans Lundbeck on August 14, 1915 and is headquartered in Valby, Denmark.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
5,707

Frequently Asked Questions

What is Market Cap of H. Lundbeck AS - Ordinary Shares - Class A?
What is the 52-week high for H. Lundbeck AS - Ordinary Shares - Class A?
What is the 52-week low for H. Lundbeck AS - Ordinary Shares - Class A?
What is H. Lundbeck AS - Ordinary Shares - Class A stock price today?
What was H. Lundbeck AS - Ordinary Shares - Class A stock price yesterday?
What is the PE ratio of H. Lundbeck AS - Ordinary Shares - Class A?
What is the Price-to-Book ratio of H. Lundbeck AS - Ordinary Shares - Class A?
What is the 50-day moving average of H. Lundbeck AS - Ordinary Shares - Class A?
How many employess does H. Lundbeck AS - Ordinary Shares - Class A has?

Latest HLUBF News

View
No HLUBF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.